Dan, Diana Camelia

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2023 | 2016 | 2014


Hamdi, Wafa; Ferjani, Hanene; Carlomagno, Raffaella; Dusser, Perrine; Echaubard, Stéphane; Belot, Alexandre; Bouayed, Kenza; Wouters, Carine; Richer, Olivier; Hentgen, Véronique; Lohse, Anne; Dan, Diana; Kaiser, Daniela; Barbier, Catherine; Cannizzaro, Elvira; Poignant, Sylvaine; Melki, Isabelle; Hofer, Michaël (2023). Factors associated with poor prognosis of hip arthritis in juvenile idiopathic arthritis: Data from the JIR cohort. Musculoskeletal care, 21(3), pp. 806-814. Wiley 10.1002/msc.1755


Villiger, Peter M; Adler, Sabine; Kuchen, Stefan; Wermelinger, Felix; Dan, Diana; Fiege, Veronika; Bütikofer, Lukas; Seitz, Michael; Reichenbach, Stephan (2016). Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet, 387(10031), pp. 1921-1927. Elsevier 10.1016/S0140-6736(16)00560-2


Dan, Diana Camelia; Fischer, Rahel; Adler, Sabine; Förger, Frauke; Villiger, Peter (2014). Cyclophosphamide: As bad as its reputation? Long-term single centre experience of cyclophosphamide side effects in the treatment of systemic autoimmune diseases. Swiss medical weekly, 144, w14030. EMH Schweizerischer Ärzteverlag 10.4414/smw.2014.14030

Dan, Diana Camelia; Bart, Pierre-Alexandre; Novy, Jan; Kuntzer, Thierry; Clair, Carole (2014). Double seronegative myasthenia gravis with antiphospholipid syndrome: a case report. Journal of medical case reports, 8(2), p. 2. BioMed Central 10.1186/1752-1947-8-2

Provide Feedback